Teladoc Health Inc (TDOC) Shares Bought by Marshall Wace North America L.P.

Share on StockTwits

Marshall Wace North America L.P. grew its holdings in shares of Teladoc Health Inc (NYSE:TDOC) by 313.5% during the third quarter, HoldingsChannel reports. The institutional investor owned 202,001 shares of the health services provider’s stock after purchasing an additional 153,146 shares during the quarter. Marshall Wace North America L.P.’s holdings in Teladoc Health were worth $17,443,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. Principal Financial Group Inc. lifted its holdings in shares of Teladoc Health by 3.4% in the 1st quarter. Principal Financial Group Inc. now owns 118,266 shares of the health services provider’s stock worth $4,767,000 after purchasing an additional 3,839 shares in the last quarter. Aperio Group LLC bought a new position in shares of Teladoc Health in the 2nd quarter worth $201,000. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of Teladoc Health by 140.9% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 23,736 shares of the health services provider’s stock worth $1,378,000 after purchasing an additional 13,883 shares in the last quarter. TD Asset Management Inc. lifted its holdings in shares of Teladoc Health by 28.9% in the 2nd quarter. TD Asset Management Inc. now owns 97,800 shares of the health services provider’s stock worth $5,677,000 after purchasing an additional 21,900 shares in the last quarter. Finally, Commonwealth Equity Services LLC lifted its holdings in shares of Teladoc Health by 13.0% in the 2nd quarter. Commonwealth Equity Services LLC now owns 24,464 shares of the health services provider’s stock worth $1,420,000 after purchasing an additional 2,809 shares in the last quarter.

In other news, VP Mark Hirschhorn sold 35,000 shares of the firm’s stock in a transaction on Tuesday, September 25th. The stock was sold at an average price of $80.42, for a total transaction of $2,814,700.00. Following the completion of the sale, the vice president now directly owns 10,000 shares of the company’s stock, valued at approximately $804,200. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Stephany Verstraete sold 18,000 shares of the firm’s stock in a transaction on Thursday, September 20th. The shares were sold at an average price of $74.79, for a total value of $1,346,220.00. Following the sale, the insider now directly owns 13,925 shares of the company’s stock, valued at $1,041,450.75. The disclosure for this sale can be found here. Insiders sold a total of 255,929 shares of company stock valued at $17,683,623 over the last three months. 3.95% of the stock is currently owned by insiders.

A number of equities analysts recently issued reports on TDOC shares. TheStreet cut Teladoc Health from a “c” rating to a “d+” rating in a report on Tuesday, October 9th. Craig Hallum increased their target price on Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, October 15th. SunTrust Banks increased their target price on Teladoc Health to $100.00 and gave the stock a “buy” rating in a report on Monday, September 24th. Canaccord Genuity increased their target price on Teladoc Health from $70.00 to $86.00 and gave the stock a “buy” rating in a report on Thursday, September 20th. Finally, Jefferies Financial Group set a $95.00 target price on Teladoc Health and gave the stock a “buy” rating in a report on Friday, November 2nd. Four analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $85.06.

NYSE TDOC opened at $53.41 on Friday. The firm has a market capitalization of $3.91 billion, a P/E ratio of -32.37 and a beta of 0.92. Teladoc Health Inc has a 12 month low of $30.88 and a 12 month high of $89.05. The company has a quick ratio of 8.99, a current ratio of 8.99 and a debt-to-equity ratio of 0.40.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Thursday, November 1st. The health services provider reported ($0.34) EPS for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.02. The business had revenue of $111.00 million during the quarter, compared to analyst estimates of $109.94 million. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. Teladoc Health’s quarterly revenue was up 61.6% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.55) EPS. Equities analysts expect that Teladoc Health Inc will post -1.47 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Teladoc Health Inc (TDOC) Shares Bought by Marshall Wace North America L.P.” was originally reported by BBNS and is the property of of BBNS. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at https://baseballnewssource.com/2018/12/08/teladoc-health-inc-tdoc-shares-bought-by-marshall-wace-north-america-l-p/3065360.html.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: Dividend Aristocrat Index

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.